TELA Bio, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $42.4M | $62.5M | $43.9M |
| FY2022 | $53.6M | $67.9M | $42.0M |
| FY2023 | $59.2M | $78.0M | $46.7M |
| FY2024 | $58.1M | $86.6M | $52.7M |
| FY2025 | $75.1M | $81.4M | $50.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $42.4M | $62.5M | $43.9M |
| FY2022 | $53.6M | $67.9M | $42.0M |
| FY2023 | $59.2M | $78.0M | $46.7M |
| FY2024 | $58.1M | $86.6M | $52.7M |
| FY2025 | $75.1M | $81.4M | $50.8M |